Nflection Is A Biopharmaceutical Company Focused On The Development Of Novel Therapies To Address The Needs Of Patients With Neurofibromatosis Type 1Immunosuppressant Mediated Squamous Cell Carcinomaand Congenital Birthmarks Such As Keratinocytic Epidermal Nevi To Address These Ras Mediated Disordersdriven By The Aberrant Activation Of The Ras Raf Mek Erk Pathwaywe Are Developing First In Class Mekmitogen Activated Protein Kinase Kinaseinhibitors As Topical Treatments
No conferences found for this company.
| Company Name | Nflection Therapeutics Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
